Data from Cancer Cell–Intrinsic SSBP4 Enables Tumor Immune Evasion by Promoting Cholesterol Biosynthesis

<jats:p>&lt;div&gt;Abstract&lt;p&gt;The immunosuppressive tumor microenvironment (TME) contributes to resistance against checkpoint inhibitors. However, the precise factors that shape the immune contexture of the TME remain elusive. In this study, we report that single-stranded DNA binding protein 4 (SSBP4), a previously uncharacterized protein, suppresses intratumoral T-cell activation by promoting excessive cholesteryl ester production in tumor cells. Overexpression of SSBP4 in tumor cells decreased T-cell infiltration and accelerated tumor growth in murine syngeneic tumor models. Conversely, genetic ablation of SSBP4 in tumor cells enhanced T-cell infiltration and inhibited tumor growth in a CD8&lt;sup&gt;+&lt;/sup&gt; T cell–dependent manner. Mechanistically, SSBP4 upregulated cholesterol synthesis genes, leading to increased production of cholesterol and cholesteryl esters in tumor cells, which directly suppressed CD8&lt;sup&gt;+&lt;/sup&gt; T-cell activation and function. Furthermore, SSBP4 abrogation significantly improved the efficacy of anti–PD-1 treatment. Thus, in this study, we have identified SSBP4 as a cancer cell-intrinsic regulator of cholesterol metabolism that contributes to tumor immune evasion.&lt;/p&gt;&lt;p&gt;&lt;a target="_blank" href="https://aacrjournals.org/cancerimmunolres/article-abstract/doi/10.1158/2326-6066.CIR-26-0635"&gt;&lt;i&gt;See related Spotlight, p. 1210&lt;/i&gt;&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</jats:p>